Conquer Cancer’s EveryGrant announces Quality Improvement grants, funded by Pfizer, to leverage technology to improve biomarker-driven testing and treatment Current clinical guidelines for multiple cancers, including colon, prostate, and lung cancers, recommend biomarker testing to properly guide treatment decisions. However, utilization and efficiency of...

We're pleased to announce @williamohmd.bsky.social has been awarded an EveryGrant from the #ConquerCancerFoundation to support “Optimizing Biomarker and Genomic Testing in #ProstateCancer: Identifying Gaps and Implementing Quality Improvement Solutions.”
conquer.org/news/conquer...